SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
9762373
Source:
http://linkedlifedata.com/resource/pubmed/id/9762373
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0030705
,
umls-concept:C0074559
,
umls-concept:C0142340
,
umls-concept:C0231239
,
umls-concept:C0936012
,
umls-concept:C1442989
,
umls-concept:C1513492
,
umls-concept:C1519031
,
umls-concept:C1705994
pubmed:issue
9
pubmed:dateCreated
1998-12-28
pubmed:abstractText
To compare the costs of pharmacotherapy in patients with Parkinson's disease before and after converting from standard Sinemet to extended-release Sinemet CR.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9203131
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antiparkinson Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Carbidopa
,
http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations
,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations
,
http://linkedlifedata.com/resource/pubmed/chemical/Levodopa
,
http://linkedlifedata.com/resource/pubmed/chemical/carbidopa, levodopa drug combination
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1060-0280
pubmed:author
pubmed-author:HempelA GAG
,
pubmed-author:MaatyM AMA
,
pubmed-author:SageJ IJI
,
pubmed-author:WagnerM LML
pubmed:issnType
Print
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
878-83
pubmed:dateRevised
2009-10-6
pubmed:meshHeading
pubmed-meshheading:9762373-Adult
,
pubmed-meshheading:9762373-Aged
,
pubmed-meshheading:9762373-Aged, 80 and over
,
pubmed-meshheading:9762373-Antiparkinson Agents
,
pubmed-meshheading:9762373-Carbidopa
,
pubmed-meshheading:9762373-Cost-Benefit Analysis
,
pubmed-meshheading:9762373-Delayed-Action Preparations
,
pubmed-meshheading:9762373-Drug Combinations
,
pubmed-meshheading:9762373-Female
,
pubmed-meshheading:9762373-Humans
,
pubmed-meshheading:9762373-Levodopa
,
pubmed-meshheading:9762373-Male
,
pubmed-meshheading:9762373-Middle Aged
,
pubmed-meshheading:9762373-Movement Disorders
,
pubmed-meshheading:9762373-Parkinson Disease
,
pubmed-meshheading:9762373-Prospective Studies
pubmed:year
1998
pubmed:articleTitle
Pharmacoeconomic analysis of using Sinemet CR over standard Sinemet in parkinsonian patients with motor fluctuations.
pubmed:affiliation
College of Pharmacy, Rutgers, State University of New Jersey, Piscataway 08854, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Research Support, Non-U.S. Gov't